Table: Jcr Pharmaceuticals - 9-MTH group results

JCR Pharmaceuticals

27/01/2022 07:00

Jan 27 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2021        Dec 31, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               40.27               19.42            52.00    
                  (+107.3 pct)         (+7.4 pct)       (+72.8 pct) 
  Operating           18.36                3.95            21.70    
                  (+364.4 pct)         (+83.6 pct)     (+162.4 pct) 
  Recurring           18.72                4.05            21.70    
                  (+362.8 pct)         (+86.3 pct)     (+155.6 pct) 
  Net                 12.92                3.26            15.40    
                  (+295.8 pct)         (+80.8 pct)     (+123.4 pct) 
  EPS              104.45 yen           26.44 yen       124.70 yen  
  EPS Diluted      104.03 yen           26.30 yen                   
  Ann Div                                                20.00 yen  
  -Q2 div           10.00 yen           18.00 yen                   
  -Q4 div                               7.50 yen         10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T